A combination antibiotic is one in which two ingredients are added together for additional therapeutic effect. One or both ingredients may be antibiotics.
Antibiotic combinations are increasingly important because of antimicrobial resistance. This means that individual antibiotics that used to be effective are no longer effective, and because of the absence of new classes of antibiotic, they allow old antibiotics to be continue to be used. In particular, they may be required to treat multiresistant organisms, such as carbapenem-resistant Enterobacteriaceae. Some combinations are more likely to result in successful treatment of an infection.
Uses
Antibiotics are used in combination for a number of reasons:
- to treat multiresistant organisms, such as carbapenem-resistant Enterobacteriaceae.
- Amoxicillin/clavulanic acid, which includes the beta lactam amoxicillin with the suicide inhibitor clauvanic acid, which helps the amoxicillin overcome the action of beta lactamase
- because a person may be infected with more than one microbe simultaneously, for example infections of the abdominal cavity after bowel perforation.
- because antibiotics used together may act synergistically to increase the efficacy of both,
- because antibiotics used together may have a broader spectrum than each antibiotic used individually.
Examples
Examples of combinations include:
- Amoxicillin/clavulanic acid, which includes the beta lactam amoxicillin with the suicide inhibitor clauvanic acid, which helps the amoxicillin overcome the action of beta lactamase
- Trimethoprim/sulfamethoxazole
Research
Research into combination antibiotics is ongoing.
References
- ^ Bassetti, Matteo; Righi, Elda (October 2015). "New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections". Current Opinion in Critical Care. 21 (5): 402–411. doi:10.1097/MCC.0000000000000235. PMID 26263298. S2CID 45984482.
- ^ Tyers, Mike; Wright, Gerard D. (25 January 2019). "Drug combinations: a strategy to extend the life of antibiotics in the 21st century". Nature Reviews Microbiology. 17 (3): 141–155. doi:10.1038/s41579-018-0141-x. PMID 30683887. S2CID 59259623.
- ^ Ahmed, A; Azim, A; Gurjar, M; Baronia, AK (May 2014). "Current concepts in combination antibiotic therapy for critically ill patients". Indian Journal of Critical Care Medicine. 18 (5): 310–4. doi:10.4103/0972-5229.132495. PMC 4047693. PMID 24914260.